tiprankstipranks
Advertisement

ARKK - ETF AI Analysis

Compare

Top Page

ARKK

Ark Innovation Etf (ARKK)

Rating:53Neutral
Price Target:
ARKK’s overall rating suggests it is a higher-risk, innovation-focused ETF with a mixed but promising outlook driven by several strong growth names. Major holdings like Tesla and AMD support the fund’s quality through solid financial performance, positive earnings calls, and strong growth potential, while Robinhood and Coinbase add to this strength despite some valuation and technical concerns. On the weaker side, Crispr Therapeutics and Roblox face profitability and bearish technical challenges, and the fund’s concentration in disruptive, often volatile tech and innovation companies is the main risk factor for investors.
Positive Factors
Focused Innovation Theme
The fund targets innovative companies in areas like health care and technology, which can benefit if disruptive businesses continue to grow over the long term.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors such as health care, technology, consumer cyclical, and financials, helping reduce the impact if one innovative industry stumbles.
Strong Recent Performance From Select Holdings
Some top positions, such as Advanced Micro Devices and Twist Bioscience, have shown strong recent gains, which can help offset weaker names in the portfolio.
Negative Factors
High Expense Ratio
The fund charges a relatively high fee, which can eat into returns over time compared with lower-cost ETFs.
Concentrated Top Holdings
A small group of companies makes up a large share of the portfolio, increasing the risk that trouble in just a few stocks could significantly hurt the fund.
Recent Weak Performance and U.S. Concentration
The ETF has recently delivered weak returns and is heavily invested in U.S. companies, which increases exposure to both short-term volatility and the U.S. market specifically.

ARKK vs. SPDR S&P 500 ETF (SPY)

ARKK Summary

ARKK (Ark Innovation ETF) is an actively managed fund that focuses on “disruptive innovation” rather than a traditional stock index. It invests mainly in U.S. companies working on new technologies in areas like artificial intelligence, robotics, genetics, and digital finance. Well-known holdings include Tesla and AMD, along with firms such as Coinbase and Shopify. Someone might invest in ARKK if they want growth potential from cutting‑edge tech and a mix of different innovative companies in one fund. However, it can be very volatile and may rise or fall sharply because it is heavily concentrated in high‑risk technology and innovation stocks.
How much will it cost me?The Ark Innovation ETF (ARKK) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, meaning experts are constantly adjusting its holdings to focus on innovative and disruptive companies.
What would affect this ETF?The Ark Innovation ETF (ARKK) could benefit from continued advancements in technology and innovation, particularly in areas like artificial intelligence, robotics, and genomics, which are key focuses of its portfolio. However, it may face challenges from rising interest rates, which can negatively impact growth-focused investments, and regulatory changes in sectors like fintech or healthcare. Global economic uncertainty could also affect the performance of its top holdings, such as Tesla and Coinbase, which are sensitive to market conditions.

ARKK Top 10 Holdings

ARKK is leaning hard into a mix of cutting-edge tech and healthcare, with a global flavor but a clear tilt toward U.S. innovators. AMD and Robinhood are doing the heavy lifting lately, with AMD riding the AI chip wave and Robinhood’s business momentum giving the fund a lift. On the biotech side, names like Twist Bioscience and Beam Therapeutics are heating up, helping offset some of Tesla’s recent wobble and Coinbase’s slump. Overall, the fund is concentrated in a handful of high-octane, innovation-first names that can swing performance quickly.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Tesla8.84%$512.16M$1.40T4.71%
73
Outperform
Tempus AI, Inc. Class A4.94%$286.41M$8.46B-27.36%
52
Neutral
SpaceX4.66%$270.04M$1.53T
Crispr Therapeutics AG4.64%$268.86M$4.56B-28.05%
40
Underperform
Coinbase Global4.43%$256.56M$43.77B-59.37%
68
Neutral
Robinhood4.37%$253.32M$94.17B-0.34%
68
Neutral
Advanced Micro Devices4.35%$252.28M$900.63B232.90%
73
Outperform
Shopify4.21%$244.00M$153.87B-8.26%
Circle Internet Group, Inc. Class A3.55%$205.98M$16.45B-67.80%
64
Neutral
10x Genomics3.53%$204.57M$5.97B250.04%
60
Neutral

ARKK Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
78.01
Negative
100DMA
75.62
Negative
200DMA
77.83
Negative
Market Momentum
MACD
-0.77
Positive
RSI
39.71
Neutral
STOCH
25.79
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ARKK, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 78.88, equal to the 50-day MA of 78.01, and equal to the 200-day MA of 77.83, indicating a bearish trend. The MACD of -0.77 indicates Positive momentum. The RSI at 39.71 is Neutral, neither overbought nor oversold. The STOCH value of 25.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARKK.

ARKK Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$5.97B0.75%
53
Neutral
$3.08B0.65%
58
Neutral
$1.96B0.75%
64
Neutral
$1.83B0.75%
58
Neutral
$1.58B0.75%
53
Neutral
$1.40B0.80%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARKK
Ark Innovation Etf
73.83
-2.96
-3.85%
FWD
AB Disruptors ETF
ARKQ
ARK Autonomous Technology & Robotics ETF
CHAT
Roundhill Generative AI & Technology ETF
ARKG
ARK Genomic Revolution ETF
SQS
Sapient Quality Select ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement